4.8 Article

2D transparent few-layered hydrogen substituted graphdiyne nano-interface for unprecedented ultralow ANXA2 cancer biomarker detection

期刊

BIOSENSORS & BIOELECTRONICS
卷 213, 期 -, 页码 -

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2022.114433

关键词

Nanobiosensor; Graphdiyne; Liver cancer; Annexin A2; Nanosheets

资金

  1. UGC fellowship [191620082661, 99/CSIRNETJUNE2019]
  2. DST [DST/INSPIRE/04/2017/001336]
  3. Institute of Eminence, University of Delhi [IoE/2021/12/FRP]

向作者/读者索取更多资源

In this study, 2D few-layered transparent hydrogen substituted graphdiyne (HsGDY) nanosheets were synthesized and their electrochemical characteristics for cancer biomarker detection were explored for the first time. The HsGDY nano-interface platform showed a wider linear detection range, high sensitivity, and unprecedented ultralow level detection ability for ANXA2 cancer biomarker.
Herein, we report synthesis of 2D few-layered transparent hydrogen substituted graphdiyne (HsGDY) nanosheets and explored its electrochemical characteristics for the first time to develop a nano-interface for cancer biomarker detection [liver cancer (LC) biomarker; ANXA2]. The semiconducting HsGDY (band gap; 1.98 eV) contains considerable number of sp and sp(2) hybridised pi-electrons with abundant hierarchical pores, thus reveals a negative peripheral charge and high surface area respectively, making it competent to immobilize mass anti-ANXA2 antibodies. The nano-interface platform is fabricated through electrophoretic deposition of HsGDY onto indium tin oxide (ITO) coated glass substrate (50V, 60s) with subsequent immobilization of anti-ANXA2 bio-molecules and bovine serum albumin (BSA) to minimize non-specific binding. The pristine HsGDY and fabricated electrodes were characterized using spectroscopic, microscopic, zetasizer, surface area and pore size analyzer as well as electrochemical techniques. The electrochemical response of fabricated HsGDY nano-interface based biosensing platform (BSA/anti-ANXA2/HsGDY/ITO) is investigated via cyclic voltammetry (CV) and differential pulse voltammetry (DPV) techniques, which covers a wider linear detection range in between 0.01 fg mL(-1) to 1000 ng mL(-1) along with an exceptional sensitivity of 13.8 mu A [log (ng mL(-1))](-1) cm(-2) and 2.8 mu A [log (ng mL(-1))](-1) cm(-2) via CV and DPV techniques, respectively. This developed biosensor has the ability for unprecedented ultralow level i.e., upto 3 molecules of ANXA2 cancer biomarker detection. Moreover, the obtained electrochemical results show excellent correlation with the concentration of ANXA2 cancer biomarker present in LC patients obtained through enzyme linked immunosorbent assay (ELISA) technique.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据